These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 9299476)

  • 1. A hypothesis describing a potential link between molecular structure and TSE strains.
    Warwicker J
    Biochem Biophys Res Commun; 1997 Sep; 238(1):185-90. PubMed ID: 9299476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both host prion protein 131-188 subregion and prion strain characteristics regulate glycoform of PrP Sc.
    Yokoyama T; Shimada K; Masujin K; Iwamaru Y; Imamura M; Ushiki YK; Kimura KM; Itohara S; Shinagawa M
    Arch Virol; 2007; 152(3):603-9. PubMed ID: 17106625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptides and proteins in neurodegenerative disease: helix propensity of a polypeptide containing helix 1 of the mouse prion protein studied by NMR and CD spectroscopy.
    Liu A; Riek R; Zahn R; Hornemann S; Glockshuber R; Wüthrich K
    Biopolymers; 1999; 51(2):145-52. PubMed ID: 10397798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species barriers in a model for specific prion protein dimerisation.
    Warwicker J
    Biochem Biophys Res Commun; 1997 Mar; 232(2):508-12. PubMed ID: 9125211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of the pathogenic conformational change of the prion protein by an attractor of low order.
    Havsteen BH
    J Theor Biol; 2004 Nov; 231(1):39-48. PubMed ID: 15363928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prion protein interconversions.
    Caughey B
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):197-200; discussion 200-2. PubMed ID: 11260800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modelling indicates that the pathological conformations of prion proteins might be beta-helical.
    Downing DT; Lazo ND
    Biochem J; 1999 Oct; 343 Pt 2(Pt 2):453-60. PubMed ID: 10510313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unraveling the details of prion (con)formation(s): recent advances by mass spectrometry.
    Principe S; Maras B; Schininà ME; Pocchiari M; Cardone F
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):697-707. PubMed ID: 18729021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into prion strains and neurotoxicity.
    Aguzzi A; Heikenwalder M; Polymenidou M
    Nat Rev Mol Cell Biol; 2007 Jul; 8(7):552-61. PubMed ID: 17585315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling a prion protein dimer: predictions for fibril formation.
    Warwicker J
    Biochem Biophys Res Commun; 2000 Nov; 278(3):646-52. PubMed ID: 11095963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein.
    Liemann S; Glockshuber R
    Biochemistry; 1999 Mar; 38(11):3258-67. PubMed ID: 10079068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transmissible spongiform encephalopathies.
    Lasmézas CI
    Rev Sci Tech; 2003 Apr; 22(1):23-36. PubMed ID: 12793772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotoxicity of the putative transmembrane domain of the prion protein.
    Haïk S; Peyrin JM; Lins L; Rosseneu MY; Brasseur R; Langeveld JP; Tagliavini F; Deslys JP; Lasmézas C; Dormont D
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):644-56. PubMed ID: 11114262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological and biochemical characteristics of prion strains conserved in persistently infected cell cultures.
    Arima K; Nishida N; Sakaguchi S; Shigematsu K; Atarashi R; Yamaguchi N; Yoshikawa D; Yoon J; Watanabe K; Kobayashi N; Mouillet-Richard S; Lehmann S; Katamine S
    J Virol; 2005 Jun; 79(11):7104-12. PubMed ID: 15890950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biology of non-conventional transmissible agents or prions].
    Dormont D
    Rev Neurol (Paris); 1998 Feb; 154(2):142-51. PubMed ID: 9773035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Unconventional transmissible agents and prion protein: is something still missing?].
    Laplanche JL
    Ann Biol Clin (Paris); 1997; 55(5):395-407. PubMed ID: 9347006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reconstitution of mammalian prion infectivity de novo.
    Baskakov IV
    FEBS J; 2007 Feb; 274(3):576-87. PubMed ID: 17288547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling the culprit in Alzheimer's disease (AD): bacterial toxic proteins - Will they be significant for the aetio-pathogenesis of AD and the transmissible spongiform encephalopathies?
    Schmitt HP
    Med Hypotheses; 2007; 69(3):596-609. PubMed ID: 17337124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.